Cyclacel Pharmaceuticals (CYCC) Insider Trading & Ownership → Urgent Nvidia Warning (From Altimetry) (Ad) Free CYCC Stock Alerts $2.00 -0.49 (-19.68%) (As of 05/3/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSocial Media Cyclacel Pharmaceuticals (NASDAQ:CYCC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.47%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$26,334.36Number OfInsiders Selling(Last 12 Months)0 Get CYCC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclacel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CYCC Insider Buying and Selling by Quarter Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Cyclacel Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/21/2023Paul McbarronInsiderBuy1,886$3.31$6,242.66 12/21/2023Spiro George RombotisCEOBuy6,070$3.31$20,091.70 (Data available from 1/1/2013 forward) CYCC Insider Trading Activity - Frequently Asked Questions Who is on Cyclacel Pharmaceuticals's Insider Roster? The list of insiders at Cyclacel Pharmaceuticals includes Paul Mcbarron, Sam L Barker, and Spiro George Rombotis. Learn more on insiders at CYCC. What percentage of Cyclacel Pharmaceuticals stock is owned by insiders? 8.47% of Cyclacel Pharmaceuticals stock is owned by insiders. Learn more on CYCC's insider holdings. Which Cyclacel Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CYCC shares in the last 24 months: Paul Mcbarron ($6,242.66), and Spiro George Rombotis ($20,091.70). How much insider buying is happening at Cyclacel Pharmaceuticals? Insiders have purchased a total of 7,956 CYCC shares in the last 24 months for a total of $26,334.36 bought. More Insider Trading Tools from MarketBeat Related Companies: Clever Leaves Insider Trading Aridis Pharmaceuticals Insider Trading Aravive Insider Trading Avenue Therapeutics Insider Trading Mustang Bio Insider Trading Agile Therapeutics Insider Trading CohBar Insider Trading Virpax Pharmaceuticals Insider Trading Phio Pharmaceuticals Insider Trading Salarius Pharmaceuticals Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:CYCC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
